Is OSI Systems (OSIS) overvalued or fairly valued?

MarketChacha shows OSI Systems's valuation in context — a trailing P/E of about 23.9, a forward P/E of about 18.3, a price-to-book of about 3.9 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is OSI Systems's revenue?

OSI Systems reported revenue of $1.7B for FY2025, with net profit of $149.6M, per official filings.

What is the share price of OSI Systems (OSIS)?

OSI Systems last traded at $209.03 (-0.6% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

OSI Systems

OSIS · NYSE · Technology · United States

$209.03-0.6%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 7:29 PM

Snapshot

TickerOSIS

ExchangeNYSE

SectorTechnology

IndustryElectronic Components

CountryUnited States

Employees7,337

HeadquartersHawthorne, United States

Market cap$3.4B

P/E (TTM)23.9

P/B3.9

Volume90.5K

Websitewww.osi-systems.com

Filings tracked2

About OSI Systems

OSI Systems, Inc. designs and manufactures electronic systems and components in the United States and internationally. It operates in three segments: Security, Healthcare, and Optoelectronics and Manufacturing. The company offers baggage and parcel inspection, cargo and vehicle inspection, hold baggage and people screening, radiation monitoring, explosive and narcotics trace detection systems, and optical inspection systems, and radio frequency (RF) equipment under the Rapiscan name. It also provides site design, installation, training, and technical support services; and turnkey security screening solutions under the S2 name. In addition, the company offers patient monitoring, cardiology and remote monitoring, and connected care systems and accessories under the Spacelabs name for use in critical care, emergency, and perioperative areas within hospitals, physicians' offices, medical clinics, and ambulatory surgery centers. Further, it provides optoelectronic devices and flex circuits under the OSI Optoelectronics, OSI LaserDiode, and Advanced Photonix names for the aerospace and defense, avionics, medical imaging and diagnostics, biochemistry analysis, pharmaceutical, nanotechnology, telecommunications, construction, and homeland security markets. Additionally, the company offers electronics manufacturing services to original equipment manufacturers and end users for medical, automotive, defense, aerospace, industrial, and consumer applications under the OSI Electronics, APlus Products, Altaflex, and PFC Flexible Circuits names; and LCD displays for medical, industrial, and consumer electronics applications. The company was incorporated in 1987 and is headquartered in Hawthorne, California.

Profile as reported by Yahoo Finance.

Who owns it

Insiders4.5%
Institutions95.5%
Public & other0.0%

503 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.15.35%
FMR, LLC11.93%
Vanguard Portfolio Management LLC7.58%
Janus Henderson Group PLC4.69%
Vanguard Capital Management LLC4.24%
Mawer Investment Management Ltd.4.02%
State Street Corporation4.02%
Capital International Investors3.76%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

Forensic scorecard

Over 3 years only 0.28× of reported profit became operating cash — the classic sign that headline earnings may be running ahead of the cash actually generated. Often explained by working capital funding growth; worth a closer look.

Cash conversion0.28×

Net margin trend7.2% → 8.7%

Margin has expanded by about 1.6 points — the business is getting more profitable.

Return on equity15.7%

Latest ROE of 15.7% — capital is generating a healthy return.

Growth qualityrev 16% · PAT 28%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $401.6M · EPS 1.56

Est. earnings growth +10.1%

Next fiscal year

Rev $1.9B · EPS 11.42

Est. earnings growth +9.6%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$197.2752-wk range$311.72

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Market cap

$3.4B

Day change

-0.6%

P/E (TTM)

23.9

Fwd P/E

18.3

P/B

3.9

Beta

1.20

Revenue (FY2025)

$1.7B

Net margin

8.7%

ROE

15.7%

Revenue CAGR (2y)

+15.8%

Profit CAGR (2y)

+27.7%

EPS (FY2025)

8.71

Net profit (FY2025)

$149.6M

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about OSIS

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$1.7B	$149.6M	8.71	8.7%	15.7%
FY2024	$1.5B	$128.2M	7.38	8.3%	14.8%
FY2023	$1.3B	$91.8M	5.34	7.2%	12.6%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q1	$453.2M	$40.2M	2.33	8.9%
2025Q4	$464.1M	$38.7M	2.22	8.3%
2025Q3	$384.6M	$20.6M	1.18	5.3%
2025Q2	$505.0M	$52.7M	3.03	10.4%
2025Q1	$444.4M	$41.1M	2.40	9.3%
2024Q4	$419.8M	$37.8M	2.22	9.0%
2024Q3	$344.0M	$17.9M	1.05	5.2%
2024Q2	$480.9M	$44.7M	2.55	9.3%
2024Q1	$405.4M	$34.0M	1.95	8.4%
2023Q4	$373.2M	$36.6M	2.11	9.8%
2023Q3	$279.2M	$12.9M	0.75	4.6%
2023Q2	$411.9M	—	2.46	—
2023Q1	$302.9M	—	1.27	—

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

8-K — Results of operations, Exhibits
SEC5/4/2026material
10-Q filing
SEC5/4/2026

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.